Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation process of organic acid lithium-L-proline salt

A technology of proline salt and organic acid lithium, applied in the field of preparation technology of organic acid lithium-L-proline salt, can solve the problems of metabolic acidosis, aggravating kidney burden, blood pH value disorder, etc. Degenerative disease, prevention of suicide risk, efficacy of enhanced efficacy

Inactive Publication Date: 2021-03-12
ANYUAN BIOTECHNOLOGY (HANGZHOU) CO LTD
View PDF6 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Lithium salts often require long-term medication in the treatment of mental diseases, and the kidney damage caused by long-term medication greatly limits the clinical application of the drug. It can lead to the disorder of blood pH value, cause metabolic acidosis, and increase the burden on the kidneys. Important impact, can effectively relieve anxiety and depression and other emotional abnormalities, and can delay the degeneration of the central nervous system, and the absorption distribution and metabolic characteristics of organic acid salts are often quite different from those of inorganic acid salts, which is expected to change the existing inorganic acid salts. The in vivo distribution of lithium salts is defective, so organic acid lithium salts have better new drug development value and market prospects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation process of organic acid lithium-L-proline salt
  • Preparation process of organic acid lithium-L-proline salt
  • Preparation process of organic acid lithium-L-proline salt

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Embodiment 1, the preparation technology of a kind of organic acid lithium-L-proline salt described in the present invention, tests the dissolubility of lithium isobutyrate, L-proline in the following solvents, judges lithium isobutyrate, Good and poor solvents for L-proline.

[0025] Take 1 mg of solute, add 100 μL of solvent, observe the dissolution, if insoluble, ultrasonically observe the dissolution for 2 minutes; if it is still insoluble, add 100 μL of solvent, observe the dissolution, if insoluble, ultrasonicate for 2 minutes and then observe the dissolution; Add solvent until the product is completely dissolved, record the total amount of solvent added, or stop the solubility test if the product is not dissolved after adding up to 1 mL, so as to judge the good solvent and poor solvent of lithium isobutyrate and L-proline .

[0026] As shown in the table below, the solubility test results of lithium isobutyrate and L-proline

[0027]

Embodiment 2

[0028] Embodiment 2, the preparation process of a kind of organic acid lithium-L-proline salt according to the present invention, adopts single solvent crystallization method to prepare lithium isobutyrate-L-proline salt, the operation steps are as follows:

[0029] Add an appropriate amount of good solvent n-butanol to the equivalent chemical equivalent of lithium isobutyrate and L-proline, dissolve it just under heating and reflux and record the amount of solvent used, stir for about 3 hours, filter while it is hot, and naturally cool and analyze Crystal, filter the solid, vacuum dry to constant weight to obtain 589.3mg white solid, the mass yield is 53.06%, send XRD and hydrogen spectrum inspection

[0030] Proton spectrum data: Deuterated reagent is: CD 3 OD

[0031] combined with Figure 1~4 , draw: the chemical equivalent ratio of lithium isobutyrate and L-proline in the precipitated solid under n-butanol is 1:1; in view of the solubility of lithium isobutyrate and L-p...

Embodiment 3

[0037] Example 3, a preparation process of organic acid lithium-L-proline salt according to the present invention, using a mixed solvent crystallization method to prepare lithium isobutyrate-L-proline salt

[0038] Add an appropriate amount of good solvent to the equivalent chemical equivalent of lithium isobutyrate and L-proline, heat and reflux to make it just dissolve, then add an appropriate amount of poor solvent until the solid is just precipitated, add a good solvent to re-dissolve, and reflux for 3 h, natural cooling and crystallization, filtering the solid, vacuum drying to constant weight to obtain 374.8mg white solid, the mass yield is 33.75%, send XRD and hydrogen spectrum inspection

[0039] Proton spectrum: deuterated reagent is: CD 3 OD

[0040] combined with Figure 9 And attached Figure 1~3 , the analysis shows that: the chemical equivalent ratio of lithium isobutyrate and L-proline in ethanol and tetrahydrofuran mixed solvent precipitation solid is 1:1; ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation process of organic acid lithium-L-proline salt, and relates to the field of synthesis and preparation of organic lithium salt micromolecular medicines. The lithium isobutyrate-L-proline salt is prepared by adopting a single solvent method and a mixed solvent method so as to achieve the purposes of development and clinical application of new organic lithium salt. The organic acid lithium-L-proline salt has positive curative effects and prevention effects on recurrent mania and depression in bipolar affective disorder, has a unique suicide risk prevention effect, can effectively relieve anxiety, depression and other emotional abnormalities, can delay central nervous system degenerative changes, and changes the in vivo distribution defects of existing inorganic lithium salt. In addition, the purpose of modifying the physical and chemical properties of a drug can be achieved by adopting a pharmaceutical eutectic or salifying technology without changingthe public valence structure of drug molecules, the clinical dosage of the lithium salt is reduced while the curative effect of central nervous system diseases is enhanced, and the occurrence of peripheral adverse reactions is avoided.

Description

technical field [0001] The invention belongs to the field of synthesis and preparation of organic lithium salt small molecule drugs, and in particular relates to a preparation process of organic lithium-L-proline salt. Background technique [0002] It is well known that lithium salt not only has a certain curative effect and preventive effect on recurrent episodes of mania and depression in bipolar disorder, but also has a unique effect of preventing suicide risk. Recent studies have found that lithium salt acts on GSK-3, Wnt , Akt and neurotransmitters to play a neuroprotective role, which has potential use in the prevention and treatment of neurodegenerative diseases including Alzheimer's disease. [0003] Lithium salts often require long-term medication in the treatment of mental diseases, and the kidney damage caused by long-term medication greatly limits the clinical application of the drug. It can lead to the disorder of blood pH value, cause metabolic acidosis, and i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/401A61K31/19A61P25/00C07D207/16C07C53/124C07C51/41C07C51/43
CPCA61K31/401A61K31/19A61P25/00C07D207/16C07C53/124C07C51/412C07C51/43C07B2200/13A61K2300/00Y02E60/10A61K33/00A61P25/28C07C229/26C07C229/08C07C227/14C07C227/42C07F1/02C12P13/24
Inventor 谭骏陈斌辉李崧陈江谢非非
Owner ANYUAN BIOTECHNOLOGY (HANGZHOU) CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products